Sulodexide to prevent blood clots from coming back
Part of Heart & circulation clinical trials.
This study tests sulodexide (a blood-vessel protective medicine) to help stop deep leg blood clots or lung clots from returning after you’ve already been treated. It may help people with higher bleeding risk who are taking or recently finished standard anticoagulant medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 75 years or older at enrollment
- You had your first deep leg clot (DVT) and/or lung clot (PE) in the past, with weak or removed triggers
- Your clot was not caused by major recent surgery, major trauma, long bed rest, or a recent cast/immobility
- You have at least one bleeding risk factor, like kidney problems, anemia, diabetes, falls, or prior stroke
- You completed at least 3 months of blood-thinner (anticoagulant) treatment, and you’ve not been off it for more than 30 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking a statin (rosuvastatin) after a recent leg blood clot (DVT) and/or lung blood clot (PE) can lower the chance of future venous clots. You might benefit if you’re at risk for more clotting and can take the study medication safely.
This trial tests whether giving medicine to prevent blood clots during varicose vein treatment is safe and helpful. It focuses on people having a minimally invasive procedure on enlarged leg veins under local anesthesia.
This study compares a clot-removal device (ClotTriever) plus standard care versus standard blood thinners alone for a deep vein clot in the leg. It aims to see which approach better improves leg symptoms and outcomes.
This trial tests if colchicine, a medicine used for gout, can reduce inflammation after a first deep vein thrombosis (blood clot in a large leg vein). It might help prevent long-term leg problems from the clot.
This trial compares a personalized approach to preventing blood clots after hip or knee replacement surgery with the standard one-size-fits-all method. The goal is to see if tailoring prevention to each patient works better and is safer.
This Phase 2 study tests whether a steroid medicine called dexamethasone can reduce inflammation after a clot (DVT) is removed in the thigh/behind-knee veins. If it works, it may help improve recovery and reduce ongoing leg problems after the procedure.
Hear when a new Venous Thromboembolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.